Probiotic and technological properties of Lactobacillus spp. Strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis

Frontiers in Microbiology

Volumn 5, Issue DEC, 2014, Pages

  Delgado, Susana ^a   Leite, Analy M O ^a,b   Ruas Madiedo, Patricia ^a   Mayo, Baltasar ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Anti Helicobacter activity; Antioxidative activity; Fermentation capability; Functional characterization; Gastric lactobacilli; Specific probiotics; Stomach microbiota

Indexed keywords

BACTERIOCIN; HYDROGEN PEROXIDE; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIOXIDATIVE ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; BILE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DYSBIOSIS; FERMENTATION; GLYCOSIDIC ACTIVITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MICROBIAL DIVERSITY; MICROBIAL VIABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; REPETITIVE EXTRAGENIC PALINDROMIC POLYMERASE CHAIN REACTION;

HELICOBACTER; HELICOBACTER PYLORI; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS REUTERI; LACTOBACILLUS VAGINALIS;

EID: 84920691194     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00766     Document Type: Article

References (33)

1. Adamson, I., Nord, C. E., Lundquist, P., Sjöstedt, S., and Edlund, C. (1999). Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J. Antimicrob. Chemother. 44, 629-640.
2. Andersson, A., Lindberg, M., Jakobsson, H., Bäckhed, F., Nyrén, P. and Engstrand, L. (2008). Comparative analysis of human gut microbiota by barcoded pyrosequencing. PlosOne 3, e2836.
3. Bik, E. M., Eckburg, P. B., Gill, S. R., Nelson, K. E., Purdom, E. A., Francois, F., et al. (2006). Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. USA 103, 732-737.
4. Bruce, M. G. and Maaroos, H. I. 2008. Epidemiology of Helicobacter pylori infection. Helicobacter 13 Suppl 1, 1-6.
5. Charteris, W. P., Kelly, P. M., Morelli, L. and Collins, J. K. (1998). Development and application of an in vivo methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J. Appl. Microbiol. 84, 759-768.
6. Claisse, O. and Lonvaud-Funel, A. (2001). Primers and a specific DNA probe for detecting lactic acid bacteria producing 3-hydroxypropionaldehyde from glycerol in spoiled ciders. J. Food Protect. 64, 833-837.
7. Cui, Y., Wang, C. L., Liu, X. W., Wang, X. H., Chen, L. L., Zhao, X., et al. (2010). Two stomach-originated Lactobacillus strains improve Helicobacter pylori infected murine gastritis. World J. Gastroenterol. 28, 445-452.
8. de Vuyst, L. and Leroy, F. (2007). Bacteriocins from lactic acid bacteria: production, purification, and food applications. J. Mol. Microbiol. Biotechnol. 13, 194-199.
9. Delgado, S., O'Sullivan, E., Fitzgerald, G. and Mayo, B. (2007). Subtractive screening for probiotic properties of Lactobacillus species from the human gastrointestinal tract in the search for new probiotics. J. Food Sci. 72, M310-M315.
10. Delgado, S., Cabrera-Rubio, R., Mira, A., Suárez, A. and Mayo, B. (2013). Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microbial Ecol. 65, 763-772.
11. EFSA. 2012. Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA Journal 10, 2740-2749.
12. Francavilla, R., Lionetti, E., Castellaneta, S. P., Magistà, A. M., Maurogiovanni, G., Bucci, N., et al. 2008. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter 13, 127-134.
13. Gänzle, M. G. (2004). Reutericyclin: biological activity, mode of action, and potential applications. Appl. Microbiol. Biotechnol. 64, 326-332.
14. Hütt, P., Shchepetova, J., Lõivukene, K., Kullisaar, T. and Mikelsaar, M. (2006). Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J. Appl. Microbiol. 100, 1324-1332.
15. Hütt, P., Andreson, H., Kullisaar, T., Vihalemm, T., Unt, E., Kals, J., et al. (2009). Effects of a synbiotic product on blood antioxidative activity in subjects colonized with Helicobacter pylori. Lett. Appl. Microbiol. 48, 797-800.
16. Johnson-Henry, K. C., Mitchell, D. J., Avitzur, Y., Galindo-Mata, E., Jones, N. L. and Sherman, P. M. (2004). Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig. Dis. Sci. 49, 1095-1102.
17. Klare, I., Konstabel, C., Müller-Bertling, S., Reissbrodt, R., Hu ys, G., Vancanneyt, M., et al. (2005). Evaluation of new broth media for microdilution antibiotic susceptibility testing of lactobacilli, lactococci, pediococci, and bifidobacteria. Appl. Environ. Microbiol. 71, 8982-8986.
18. Koeuth, T., Versalovic, J. and Lupski, J. R. (1995). Differential subsequence conservation of interspersed repetitive Streptococcus pneumoniae BOX elements in diverse bacteria. Genome Res. 5, 408-418.
19. Kullisaar, T., Zilmer, M., Mikelsaar, M., Vihalemm, T., Annuk, H., Kairane, C., et al. (2002). Two antioxidative lactobacilli strains as promising probiotics. Int. J. Food Microbiol. 72, 215-224.
20. LeBlanc, J. G., Ledue-Clier, F., Bensaada, M., de Giori, G. S., Guerekobaya, T., Sesma, F., et al. (2008). Ability of Lactobacillus fermentum to overcome host alpha galactosidase deficiency, as evidenced by reduction of hydrogen excretion in rats consuming soya alpha-galacto-oligosaccharides. BMC Microbiol. 8, 22.
21. Li, X. X., Wong, G. L.H., To, K. F., Wong, V. W. S., Lai, L. H., Chow, D. K. L., et al. (2009). Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PlosOne 4, e7985.
22. López-Brea, M., Alarcón, T., Domingo, D. and Díaz-Regañón, J. (2008). Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates. J. Antimicrob. Chemother. 61, 139-142.
23. Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham. D., et al. (2007). Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 56, 772-781.
24. Martín, R., Olivares, M., Marín, M. L., Xaus, J., Fernández, L. and Rodríguez, J. M. (2005). Characterization of a reuterin-producing Lactobacillus coryniformis strain isolated from a goat's milk cheese. Int. J. Food Microbiol. 104, 267-277.
25. Martín, R. and Suárez, J. E. (2010). Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl. Environ. Microbiol. 76, 400-405.
26. Peek, R. M. and Blaser, M. J. (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2, 28-37.
27. Ross, S., Engstrand, L. and Jonsson, H. (2005). Lactobacillus gastricus sp. nov., Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov. and Lactobacillus ultunensis sp. nov., isolated from human stomach mucosa. Int. J. Syst. Evol. Microbiol. 55, 77-82.
28. Ryan, K. A., Jarayaman, T., Daly, P., Canchaya, C., Curran, S., Fang, F., et al. (2008a). Isolation of lactobacilli with probiotic properties from the human stomach. Lett. Appl. Microbiol. 47, 269-274.
29. Ryan, K. A., Daly, P., Li, Y., Hooton, C. and O'Toole, P. W. (2008b). Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J. Antimicrob. Chemother. 61, 831-834.
30. Sgouras, D., Maragkoudakis, P., Petraki, K., Martinez-Gonzalez, B., Eriotou, E., Michopoulos, S., et al. (2004). In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl. Environ. Microbiol. 70, 518-526.
31. Song, Y. L., Kato, N., Matsumiya, Y., Liu, C. X., Kato, H. and Watanabe, K. (1999). Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants. J. Clin. Microbiol. 37, 3062- 3064.
32. Sykora, J., Valeckova, K., Amlerova, J., Siala, K., Dedek, P., Watkins, S., et al. (2005). Effects of a specially designed fermented milk product containing probiotic Lactobacillus ca sei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J. Clin. Gastroenterol. 39, 692-698.
33. Tuomola, E. M. and Salminen, S. J. (1998). Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int. J. Food Microbiol. 41, 45-51.